FDA approves OraSure’s 30-minute Ebola virus diagnostic

FDA approves OraSure’s 30-minute Ebola virus diagnostic

30-minute Ebola virus diagnostic

The FDA approved its first rapid in vitro diagnostic for confirming Ebola virus infections, with potential results in about a half-hour. OraSure’s OraQuick Ebola test searches for virus antigens in samples to provide an early, probable readout that must later be confirmed with another test.

Sourced through Scoop.it from: www.fiercebiotech.com

Who We Are

Omnica Corporation is a privately-held design, engineering, and medical product development firm located in Irvine, California. The 28-person company is staffed with full-time employees and has been in operation since 1984. Our speciality is custom product development for the medical industry and industrial fields.

Our expertise is developing complex medical devices.Technical personnel at Omnica includes designers, mechanical engineers, electronic and software engineers, advanced R&D specialists, regulatory staff (for FDA documentation), machinists and model makers.

Learn MoreOmnica Corporation

Leave a Reply

Your email address will not be published. Required fields are marked *